We first surveyed articles in the PubMed database with the terms of “hormone including” “follicle-stimulating hormone” OR “FSH”, “androgen” OR “testosterone”, “estrogen” OR “17β-estradiol”, “insulin”, “insulin-like growth factors” OR “IGF”, “relaxin”, “thyroid hormone”, “retinoic acid”, “PI3K/AKT”, “Sertoli cell”, “blood-testis barrier” OR “BTB”, “in testes”. We then selected articles that met the criteria that hormones exert influences on SC development by regulating the PI3K/AKT signaling (Table 1). Further, we collected articles by searching terms containing “Sertoli cell secretion” (including “SCF”, “GDNF”, “AMH”, “transferrin”, “ABP”, “connexin 43”, “ZO-1”, “occludin”, “claudin”, “N-cadherin”, “β-catenin”, “vimentin”), “germ cell development” (including “spermatogonia proliferation” OR “spermatogonia self-renewal”, “spermatogonia differentiation”, “spermatocyte meiosis”, “spermiogenesis”, “sperm maturation”, “sperm release” OR “spermiation”), and “spermatogenesis”. Articles that were aimed at exploring the role of SC secretions in spermatogenesis were collected (Table 2). The final screening was related to “male infertility”, “male fertility diseases” OR “male reproductive diseases” where we found two notable diseases cryptorchidism and the Sertoli cell-only syndrome (SCOS). Hence, we subsequently searched for “cryptorchidism”, “the Sertoli cell only syndrome” OR “SCOS” to gain insight into their mechanisms. More papers were selected from these review articles and their reference lists.

In the fetal cells of mice and rats, immature SCs proliferate to increase their number (Lucas et al., 2014b). However, during the prepubertal period, SC proliferation stops and they start to differentiate to a mature state. During this process, SCs establish the BTB and acquire the ability to sustain spermatogenesis (Sharpe et al., 2003). It has been documented that several hormones participate in SC proliferation, maturation, and BTB junction protein expression or a part of these processes. We have summarized these hormones below (Fig. 1).

Follicle-stimulating hormone (FSH) belongs to the glycoprotein hormone family (Kumar et al., 1997). It is a crucial hormone in the endocrine regulation of spermatogenesis (Themmen and Huhtaniemi, 2000). After binding to FSH, the follicle-stimulating hormone receptor (FSHR) is activated which stimulates the downstream signaling cascades in SCs (Walker and Cheng, 2005).

Several studies have proven that FSH is required for immature SC proliferation (Griswold et al., 1977; Orth, 1984; Kumar et al., 1997; Abel et al., 2000; Crépieux et al., 2001; Wreford et al., 2001; Hayes et al., 2001; Johnston et al., 2004). Additional studies suggest that the level of p-AKT significantly increases after treatment with FSH. Moreover, reports showed that concurrent treatment with the PI3K inhibitor, LY294002/wortmannin, alone or combined with the mTOR inhibitor rapamycin, significantly decreases FSH-stimulated p-AKT levels (Meroni et al., 2002; McDonald et al., 2006; Musnier et al., 2009; Riera et al., 2012; Xi et al., 2022) and FSH-stimulated [3H] thymidine incorporation (Riera et al., 2012). In another study, FSH was also found to suppress the cytoplasm-to-nucleus translocation of transcription factor EB (TFEB) via PI3K/AKT/mTORC1 in cultured goat SCs. This further lower lysosomal biogenesis, inhibits autophagy, promotes cell survival, and enhances the expression of ABP, SCF, and GDNF (Xi et al., 2022). Besides, FSH was also found to be related to lactate production, lactate dehydrogenase (LDH) activity, and glucose uptake in a PI3K/AKT-dependent manner to provide nutrients to SCs and GCs in another report (Meroni et al., 2002). Another study showed that FSH also regulates PI3K/AKT downstream target gene c-myc, an essential factor in the regulation of cellular proliferation and the SC cycle. After treating primary SCs with FSH, there was an increase of mRNA levels of c-myc (Lim and Hwang, 1995). Similarly, another regulator of cell growth, Hypoxia Inducible Factor (HIF), which is involved in the regulation of rat SC proliferation by FSH (Gorga et al., 2018) was also shown to be related to PI3K/AKT signaling during spermatogenesis (Wang et al., 2021). Another report found that while FSH stimulates aromatase activity and estradiol production, a hormone playing a key role in the proliferation of SCs (Wu et al., 2015; Yang et al., 2015), these stimulatory effects of FSH on aromatase and estradiol are blocked by inhibiting PI3K/AKT signaling (McDonald et al., 2006). The expression of anti-Müllerian hormone (AMH), another SC-produced hormone, is triggered by SOX9 in immature SCs, and is regulated by SF1, GATA, FSH, and other factors (Rey et al., 2003). It has been documented that the expression and translocation of some of these genes are regulated mainly through the cAMP/PKA pathway in the SC line SMAT1, which possibly also involves the role of other kinases in this process, such as PI3K/AKT (Lasala et al., 2011). AMH was also shown to increase the expression of an important regulator of spermatogenesis, SCF (ur Rehman et al., 2017).

Mature SCs cease to proliferate and begin to differentiate. They respond to FSH by stimulating cAMP production (Crépieux et al., 2001; Dupont et al., 2010; Nascimento et al., 2013; Nascimento et al., 2016; Bhattacharya et al., 2019; Bhattacharya et al., 2021) instead of PI3K/AKT. This is due to the inhibition of the PI3K/AKT pathway resulting from high level cAMP (Eskola et al., 1993; Nascimento et al., 2016) and enhanced PTEN activity (Dupont et al., 2010).

Testosterone is the major androgen in the testes, which is predominantly produced by Leydig cells and can pass through the plasma membrane to interact with the intracellular androgen receptor (AR) (Walker, 2021). In the testis, only Leydig cells, peritubular cells, and SCs express AR (Lyon et al., 1975). There are two types of AR signaling: the classical signaling pathway and the non-classical signaling pathway. It is known the PI3K/AKT signaling is involved in the non-classical signaling pathway of AR. Here, testosterone interacts with AR to activate the PI3K/AKT pathway directly by activating the PI3K subunit p85a. Phosphorylated AKT activates Src, a component of another non-classical AR signaling pathway type, and contributes to AR translocation from the cytoplasm to the plasma membrane (Deng et al., 2017).

Previous studies have reported that the androgen can regulate spermatogenesis and BTB junction proteins. This regulation can be the androgen alone (Meng et al., 2005; Zhang et al., 2005; Denolet et al., 2006; Wang et al., 2006; Kaitu’u-Lino et al., 2007; Yan et al., 2008; Willems et al., 2010; Chakraborty et al., 2014; Chojnacka et al., 2016b) by working with FSH synergistically (McLachlan et al., 1994; Haywood et al., 2003; Johnston et al., 2004; Abel et al., 2008; Bhattacharya et al., 2019). Other studies showed that several compounds have an impact on SC proliferation and BTB junction proteins through the AR/PI3K/AKT pathway. For example, Lycium barbarum polysaccharide (LBP) resists heat-stress-induced injury of SCs by increasing the expression of the androgen receptor and activates the AKT signaling pathway in rats. As a result, it restores the proliferation activity of SCs by resisting the induction of Ki67 expression. It reverses the dedifferentiation of SCs by decreasing CK-18 expression, while increasing the expression levels of junction proteins occludin and ZO-1 (Hu et al., 2021a). In another report, Wuzi Yanzong Pills (WYP) improved SC viability and proliferation, ameliorated dedifferentiation and the expression of junction proteins such as ZO-1 and occludin damaged by heat stress via AKT signaling (Hu et al., 2021b; Xu et al., 2021), which may result from T-level restoration (Xu et al., 2014; Hu et al., 2021b). Ouabain is an endogenous cardiotonic steroid (Cavalcante-Silva et al., 2017), and is known to participate in the non-classical AR pathway (Ni et al., 2020). Treatment of the SC line 93RS2 with ouabain activated c-Src/c-Raf/Erk1/2 signaling, which is radically triggered by testosterone (Konrad et al., 2011; Cavalcante-Silva et al., 2017; Rajamanickam et al., 2017). Moreover, another study showed that ouabain induces PI3K/AKT phosphorylation in primary rat SCs (Lucas et al., 2012), but it was not clear whether PI3K/AKT signaling also was triggered by testosterone. In addition, Testosterone treatment can increase c-Src phosphorylation. However, 2-hydroxyflutamide (HF), an anti-androgen compound, inhibits the increase of c-Src activity induced by testosterone in 20-day-old rat testes. At the same time, HF augments AKT phosphorylation by upregulating PTEN phosphorylation, indicating the activation of the PI3K/AKT pathway. This is probably because testosterone is unable to exert functions properly. Besides, HF also reduces the level of SC functional marker connexin 43, which results from the activated PI3K/AKT pathway (Chojnacka et al., 2016a). On the contrary, long-term exposure to phenanthrene (Phe), downregulates the GDNF/PI3K/AKT signaling pathway, reduces SC numbers, and inhibits the expression of SC markers such as FSHR, WT1, and Sox9. These observations may be related to the reduction of AR expression (Chen et al., 2021; Huang et al., 2021). In another study, treating TM4 cells (normal mouse testis Sertoli cell line) with just 20 μM of nonylphenol (NP) increased the p-AKT level (Liu et al., 2016). However, treating prepubertal SCs with 30 μM NP, triggers apoptosis related to oxidative stress, disturbs the PI3K/AKT/mTOR pathway and the functions of the hormone receptor and SC secretory function, inducing reproductive damage (Huang et al., 2016). These changes are possible because of the reduction of the androgen level or the androgen receptor (Huang et al., 2016; Jambor et al., 2016; Liu et al., 2016).

To summarize, androgen stimulates the proliferation of SCs and regulates BTB junction protein expression via the PI3K/AKT pathways. While previous research was focused on classical pathways and the EGFR/Src/Ras/CREB non-classical pathway, additional research is needed to elucidate the function of AR/PI3K/AKT signaling.

In young animals, estrogens are synthesized mainly by SCs, while in adult animals, Leydig and germ cells can also synthesize these hormones (Carreau et al., 2006; Carreau and Hess, 2010). The action of certain aromatase can transform testosterone into estrogen (Walker, 2021). This then functions in male reproduction and male fertility (Lazari et al., 2009). Estrogens perform their biological functions by interacting with the classical nuclear estrogen receptors (ESRs): ESR1 and ESR2 (also known as ERα and ERβ) and also the non-classical membrane receptor, a G protein-coupled estrogen receptor 1 (GPER, also known as GPR) (Aquila et al., 2004; Royer et al., 2012). All these three receptors have been shown to activate the PI3K/AKT pathway (Lucas et al., 2014b). Once bound to estrogen, ESR1, and GPER can activate Src and EGFR, which then activates PI3K/AKT signaling. However, ESR2 activates the PI3K/AKT pathway directly after binding to estrogen.

The main physiological estrogen for male germ cell survival is 17β-estradiol (E2) (Pentikäinen et al., 2000). Treatment of cultured immature boar Sertoli cell with E2 activates mTOR in a time dependent manner, whereas 10-DEBC (an inhibitor of AKT) treatment reduces E2-induced mTOR phosphorylation significantly, suggesting an activation of PI3K/AKT/mTOR signaling. Further, the mTOR inhibitor, rapamycin, reduces the mRNA levels of SKP2, CCND1, and CCNE1 mRNA and the protein levels of RB and EMI1 to suppress E2-induced SC proliferation (Yang et al., 2015).

Studies show that ESR1 stimulates SC proliferation by upregulating CCND1 expression (Royer et al., 2012; Lucas et al., 2014a; Macheroni et al., 2020). It is a vital gene of the cell cycle, and this effect depends on NF-κB activation (Lucas et al., 2014a). However, a study showed that E2 and DPN (the ESR2-selective agonist) increase the expression of CDKN1B, GATA-1, and DMRT1 in a PI3K and CREB-dependent manner (Lucas et al., 2014a). Similarly, E2 and G-1 (the GPER-selective agonist) rapidly activate PI3K/AKT and CREB, which may participate in the upregulation of anti-apoptotic proteins BCL2 and BCL2L2 (Royer et al., 2012). Further, both G-15 (a GPR30 antagonist) and PP2 (a Src inhibitor) inhibit E2-induced activation of PI3K, indicating both GPR30 and Src participate in E2-induced PI3K/AKT phosphorylation. Besides, the activation of PI3K/AKT also enhances Skp2 expression, which contributes to SC proliferation (Yang et al., 2017).

Some chemical treatments also confirm that estrogen acts through the PI3K/AKT signaling pathway. An example is zearalenone (ZEA) (Zheng et al., 2016; Wang et al., 2018a; Zheng et al., 2018; Rogowska et al., 2019), an exogenous compound that resembles the structure of natural estrogens in its chemical structure (Rogowska et al., 2019). It arrests the cell cycle in the G2/M phase to inhibit SC proliferation (Wang et al., 2018a) and triggers autophagy via inhibition of the PI3K/AKT/mTOR pathway (Wang et al., 2018a; Zheng et al., 2018). Further, studies have shown that the autophagy stimulated by ZEA leads to damage to cytoskeletal structures (F-actin, α-tubulin, and the nucleus structure) (Zheng et al., 2016, 2018). Besides the damage to the cytoskeletal structure, one of these studies also shows that ZEA treatment can affect the secretion of specific proteins of SCs like ABP, transferrin, vimentin, N-cadherin, and FSHR (Zheng et al., 2016). Another structural analog of estradiol, Bisphenol-A(BPA) (Chianese et al., 2018), an endocrine-disrupting chemical, can also compete with E2 for ESR. BPA treatment of cultured SCs increases the protein level of PTEN while decreasing the levels of p-AKT and procaspase-3, suggesting that the PTEN/AKT pathway is involved in the apoptotic effects of BPA on SCs (Wang et al., 2015). Another molecule, diosgenin induces ESR1 and ESR2 translocation from the nucleus to the plasma membrane, which is an SRC-dependent process. This process activates ERK/AKT signaling and induces the transcriptional activity of ESR, which subsequently directly regulates the cell cycle and apoptosis proteins, such as cyclin D and Bcl-2, leading to final cell proliferation (Wu et al., 2015). Treating TM4 cells with just 20 μM of nonylphenol(NP) increased the p-AKT level (Liu et al., 2016). However, treating prepubertal SCs with 30 μM NP, triggers apoptosis related to oxidative stress, disturbs the PI3K/AKT/mTOR pathway and induces reproductive damage (Huang et al., 2016). These changes are attributed to the targeting of estrogen receptors (Huang et al., 2016; Jambor et al., 2016; Liu et al., 2016).

The insulin family of growth factors includes insulin, insulin-like growth factor I (IGF-1), insulin-like growth factor II (IGF-2), and relaxin. Though they are all structurally small polypeptides, they are key regulators of cell growth, cell metabolism, and male reproduction.

Insulin and IGF1 exert biological functions by activating their receptors: the insulin receptor (IR, also known as INSR), and the IGF-1 receptor (IGF-1R), respectively which are tyrosine kinases (Meroni et al., 2019). Notably, insulin could activate both INSR and IGFR (Escott et al., 2014). This makes it sometimes difficult to affirm the effects induced whether by insulin or IGF-I when both receptors exist.

Both insulin and IGFs have been shown to regulate the PI3K/AKT pathway in SCs. For example, in prepubertal rat SCs, unlike FSH, insulin stimulation leads to an increase in PTEN phosphorylation, the PI3K major down-regulator. This activates the PI3K/AKT pathway to promote SC proliferation and resist the shift of SCs from proliferation to differentiation states induced by FSH (Dupont et al., 2010). Similarly, IGFs also promote immature SC proliferation through the IGF/PTEN/PI3K pathway (Neirijnck et al., 2019). Besides, they are also reported to regulate aspects of SC metabolism, such as calcium uptake, amino acid and glucose transport, and lactate secretion (Oliveira et al., 2012; Escott et al., 2013; Escott et al., 2014; Faure et al., 2016; Gan et al., 2022). These are all important in SC survival through the PI3K/AKT pathway (Escott et al., 2013; Gan et al., 2022). The downstream factor p-rpS6 of mTOR was shown to disrupt IGF-1/insulin-AKT signaling that leads to an increase of MMP-9 expression. This subsequently perturbs the BTB by downregulating tight junction proteins such as claudin-11, occludin and ZO-1 (Mok et al., 2014), suggesting a protective effect of IGF-1/insulin-AKT signaling on the BTB.

IGF acts synergistically with FSH to activate AKT (Froment et al., 2007; Musnier et al., 2009). In addition, it was shown that IGF1 is required for the activation of AKT by FSH in immature SCs. For example, pre-treatment of these cells with NVP-AEW541, an IGF1R inhibitor, inhibits FSH-dependent AKT308 phosphorylation (Cannarella et al., 2019). In SCs lacking INSR and IGF1R, The expression of the fshr gene and AKT activation are both decreased (Pitetti et al., 2013). FSH was shown to stimulate immature SCs to secrete IGF1 and amplify the IGF-mediated PI3K/AKT signaling pathway in immature SCs (Khan et al., 2002; Pitetti et al., 2013). However, another report showed that FSH activates PI3K/AKT signaling in 20-day-old SCs independently of IGF-1 (Meroni et al., 2004), implicating that the interaction between IGF and FSH depends on the developmental phase of SCs.

Interestingly, a study showed that knocking out follistatin-like 3 (FSTL3), a glycoprotein that binds and inhibits the action of TGFβ ligands increases SC numbers, which might arise from the increased IGF1/AKT signaling. This result demonstrates a cross-talk between TGF ligands and IGF/AKT signaling for cell survival (Oldknow et al., 2013).

Relaxin (RLN/RLX) is another member of the insulin family of growth factors, the structure of which is similar to that of insulin. Relaxin binds to the relaxin family of peptide receptors (RXFP1 and RXFP2) (Hsu et al., 2002), which belong to the G-protein coupled receptor (GPCR) family, and stimulate several crucial signaling pathways (Bathgate et al., 2013).

Relaxin has been shown to stimulate SC proliferation (Cardoso et al., 2010; Nascimento et al., 2012; Pimenta et al., 2013, 2015; Nascimento et al., 2016). Further, relaxin increases the incorporation of [3H]-thymidine (Cardoso et al., 2010; Nascimento et al., 2012, 2016) and PCNA levels in SCs (Nascimento et al., 2012). Other studies show that relaxin stimulates SC proliferation due to the activation of the PI3K/AKT pathways (Nascimento et al., 2013). In SCs isolated from 15-day-old rats at a stage that is close to the transition between cell proliferation and cell differentiation, relaxin and FSH affect the same signaling pathways in opposite directions. While relaxin increases AKT phosphorylation, inhibits basal cAMP production, and impacts NF-κB nuclear translocation, FSH inhibits AKT phosphorylation and strongly increases cAMP production as well as CREB phosphorylation (Nascimento et al., 2013, 2016). To summarize, relaxin counteracts FSH signaling but does not block its pro-differentiation function triggered by FSH in 15-day-old rats.

Thyroid hormones (THs) are critical regulators of cell growth, cell development, and cell metabolism in almost all tissues (Oetting and Yen, 2007; Cheng et al., 2010; Brent, 2012). The thyroid gland mainly secretes two types of THs, levothyroxine (T4) and triiodothyronine (T3), where the latter is identified as the more biologically active form (Sinha and Yen, 2016). The expression of the thyroid hormone receptor (TR) within the seminiferous epithelium only occurs in SCs, and the Tαreceptor is its only form expressed (Jannini et al., 2000). There are two main pathways by which THs exert their functions, namely genomic and non-genomic. The former refers to the influences of gene expression, while the latter refers to the regulation of the intracellular signaling pathways, including PI3K/AKT (Geist et al., 2021).

T3 has been shown to inhibit SC proliferation via the PI3K/AKT signaling pathway (Sun et al., 2015; Wang et al., 2019). This is accomplished by downregulating cyclinA2, cyclinD1, cyclinE1, PCNA, and Skp2 (Holsberger and Cooke, 2005; Sun et al., 2015; Wang et al., 2019) and upregulating the cyclin-dependent kinase inhibitors (CDKI) p21Cip1, and p27Kip1 (Buzzard et al., 2003; Holsberger et al., 2003, 2005; Holsberger and Cooke, 2005; Sun et al., 2015; Wang et al., 2019). Therefore, T3 and the above-mentioned hormones have opposite effects on SC proliferation even though they can both affect the PI3K/AKT signaling.

It is worth noting that Cx43 could be an intermediate target for T3 inhibition of neonatal SC proliferation (Gilleron et al., 2006), which has been shown to be an inhibitor of Skp2 in a previous study (Zhang et al., 2003). This offers a new thought that T3 is capable to upregulate connexin 43 expression, one of the main components of the BTB under the control of the PI3K/AKT signaling pathway. Further, T3 also possibly promotes SC differentiation via PI3K/AKT signaling by upregulating AR and down-regulating KRT-18 (Wang et al., 2019).

The hormones summarized above have indirect effects on spermatogenesis by stimulating SC secretion through PI3K/AKT signaling. These secretions mainly include cytokines and hormones, like SCF, GDNF, and AMH and transport proteins, like ABP, and transferrin. They also include cell junction proteins, like ZO-1, occludin, claudin, connexin 43, β-catenin, and N-cadherin along with cellular metabolites, like amino acid, glucose, LDH, and HIF. Some SC secretions have been shown to play important roles in regulating spermatogenesis (Fig. 2).

Spermatogenesis originates from the self-renewal of SSCs (Lord et al., 2018). They then differentiate into types A₁–A₄, intermediate (Int), and B spermatogonia successively (Li et al., 2019). This process is regulated by several cytokines secreted by SCs in a paracrine manner.

GDNF, produced by SCs, and its receptor GFRA1 is expressed on the surface of SSCs. The GDNF-GFRA1 complex interacts with RET tyrosine kinase, which is present on the surface of undifferentiated type A spermatogonia (Naughton et al., 2006; He et al., 2007). This promotes spermatogonial self-renewal in mice (Meng et al., 2000; Kubota et al., 2004; Hofmann et al., 2005; Wang et al., 2014).

SCF, specifically produced by SCs acts through its receptor KIT, which is encoded by c-kit. The stem cell factor (SCF)/KIT pathway is known to regulate type A spermatogonia proliferation and differentiation (Blume-Jensen et al., 2000; Feng et al., 2000; Ohta et al., 2000; Feng et al., 2002). Its effects on spermatogonia proliferation are induced by type A spermatogonial DNA synthesis (Feng et al., 2000). However, studies have shown that the SCF/KIT signaling also appears to be necessary for maintaining the proliferation of differentiated spermatogonia but not for the initiation of spermatogonial cell differentiation (Yoshinaga et al., 1991; Tajima et al., 1994; Hakovirta et al., 1999; Ohta et al., 2000, 2003). To elaborate, undifferentiated type A spermatogonia or SSCs are independent of KIT. Interestingly, a review states that KIT also regulates the effects of both bone morphogenetic protein 4 (BMP4) and retinoic acid (RA) on spermatogonial differentiation including SSCs (Hai et al., 2014). In cryptorchid patients, SCF and RA promote human SSCs differentiating into haploid spermatids, which can be a potential approach for treating this disease (Yang et al., 2014).

In SC specific connexin 43 knockout (SCCx43KO) mice, the germ cell numbers are significantly reduced, causing Sertoli-cell-only (SCO) syndrome, and spermatogenesis is arrested at the level of undifferentiated spermatogonia (Steger et al., 1999; Brehm et al., 2007; Rode et al., 2018). This suggests a defect of spermatogonia differentiation, which may be associated with the gene expression of Sohlh1, Lhx8, and Sox3 (Giese et al., 2012).

SCs play an active role in the transfer of spermatocytes to the adluminal compartment mainly because of the BTB structure (Russell, 1977).

The expression of the major components of the BTB, ZO-1, occludin, and claudin, plays an important role in the migration of spermatocytes through the BTB. Another cell junction protein, connexin 43 restores meiosis and the BTB structure under the situation of aspermatogenesis and barrier disruption caused by toxicant, but it fails to support round spermatids to enter spermiogenesis (Li et al., 2016). Further, in SCCx43KO the gene expression of Ovol1, Dazl, Stra8, Sox3, Sycp2, Piwil2, and Ddx25 are changed. These play pivotal roles in the initiation or progression of meiosis and controlling apoptosis in spermatocytes (Giese et al., 2012). Additionally, Cx43 is also required for the mitosis-meiosis switch (Hilbold et al., 2020).

Spermatogenesis is also a transferrin-dependent process, which is primarily secreted by SCs and can transport iron into the seminiferous tubule (Wauben-Penris et al., 1986; Morales et al., 1987). Transferrin receptors (TFRC) are localized mainly in spermatocytes and early spermatids (Sylvester and Griswold, 1984; Forti et al., 1989). Further, TFRC is essential for spermatocyte meiosis progression, particularly for DNA damage repair and chromosome synapsis (Gao et al., 2021).

Another SC secretion is androgen-binding protein (ABP), the receptor of which is expressed by spermatocytes (Gerard, 1995). It is also shown to increase the secretion of specific spermatocyte proteins individually (Sharpe et al., 1992).

Round spermatids differentiate into spermatozoa, which then are released into the tubular lumen at spermiation (Qian et al., 2014). SCs play an essential role during sperm maturation and release, mainly by forming Sertoli cell-spermatid adhesion. In the initial stages, round spermatids are linked to SCs by desmosomes before spermiogenesis occurs. Round spermatids then begin to elongate and apical ectoplasmic specialization (ES) replaces desmosome anchors gradually. This ES disassembles before sperm release (Wang et al., 2022). Additionally, cytokines secreted by SCs (such as EGF), also regulate sperm maturation (Naz et al., 1994).

SC-expressed Cx43 affects sperm development. For example, SCCx43KO changes the expression of Spag6, Zpbp2, Taf7l, and Tex11 which are essential genes for sperm count, sperm formation, and maturation (Giese et al., 2012).

Sperm production and maturation are also androgen-dependent processes. ABP works with androgen to regulate the sperm-fertilizing ability (Anthony et al., 1984b; Hermo et al., 1998). The hypophysectomized rat model, which maintains a low testosterone level with pregnenolone, also verifies this result (Anthony et al., 1984a). Further, ABP mRNA levels can be upregulated by estradiol, and this increase could upregulate the expression of transition protein 1 (TP1) involved in nuclear chromatin condensation in rodent spermatids in vitro (Caron et al., 2001; Kierszenbaum, 2001; Della-Maria et al., 2002; Aleem et al., 2006).

Hormones play important roles in the process of reproduction and are attracting increased attention from researchers. Studies show male infertility diseases, like cryptorchidism (Rodprasert et al., 2019; Aldahhan et al., 2021) and the Sertoli cell-only syndrome (SCOS) (Jain and Halder, 2012) usually document disrupted hormone levels. In cryptorchid testes, the FSH and androgen receptors of SCs are dramatically reduced (Agoulnik et al., 2012). Most SCOS testes have low inhibin B but high FSH levels (Jain and Halder, 2012). Hence, detecting the relevant hormone level change can be used as a means of diagnosis, and regulation of hormone levels. This offers a potentially feasible treatment method for male infertility diseases.

Many studies show that infertility in men is mainly (more than 90%) caused by low sperm counts, poor sperm quality, or both (Leaver, 2016). This indicates that the disruption of spermatogenesis is the major cause of male infertility. We have summarized that spermatogenesis is regulated by hormone-mediated signaling pathways, including PI3K/AKT, and its subsequent effects on SC secretions. Therefore, regulating the PI3K/AKT signaling in SCs (such as using their activators/inhibitors or changing the levels of related hormones) and SC secretions is also a good idea for regulating spermatogenesis and treating male infertility. For example, in cryptorchid testes, the ability of SCs to secrete inhibin B and AMH is affected (Cortes et al., 2016). Further, spermatogenesis is arrested at the undifferentiated type A spermatogonia stage and germ cell apoptosis increases significantly (Agoulnik et al., 2012). However, the SC secretions, SCF and RA promote the differentiation of human SSCs into haploid spermatids in cryptorchid patients (Yang et al., 2014). SCOS, also a major cause of male infertility is characterized by a lack of germ cells, and the seminiferous tubules contain only SCs (Talati and Sheikh, 1991). Most SCs in SCOS can neither organize cell-cell junctions nor stimulate SSCs to produce normal levels of growth factors, such as GDNF, FGF8, and BMP4 (Paduch et al., 2019). The failure of SCs to form normal CX43 junction protein is associated with impaired spermatogenesis in SCO testis (Defamie et al., 2003), including spermatogonia differentiation, spermatocyte meiosis, and sperm maturation (Giese et al., 2012). Additionally, the downregulation of GDNF is associated with reduced spermatogonial self-renewal (Meng et al., 2000; Kubota et al., 2004; Hofmann et al., 2005; Wang et al., 2014). Hence, detecting the level of SC secretions such as inhibin B, AMH, SCF, RA, GDNF, FGF8, BMP4, and CX43 can be used as a means of diagnosis. Further, the regulation of their levels may be a potential treatment method of male infertility diseases.

Therefore, the regulation of hormone levels, the PI3K/AKT signaling, SC secretions, and finally spermatogenesis may be promising methods for treating male infertility, like cryptorchidism and SCOS.